Insider-Einblicke in Pharma-Karrierestrategie, den DACH-Arbeitsmarkt, LinkedIn, ATS-Systeme und Executive Recruitment. Das Wissen aus 13 Jahren auf der anderen Seite des Schreibtischs — geschrieben für die Kandidaten, die es verdienen, es zu erfahren.
Die neuesten Artikel erscheinen auf Englisch – der Arbeitssprache des internationalen Pharma-Recruitings.
Die Qualifikationen, die realistischen Einstiegswege und worauf Recruiter und das ATS bei CRA-Rollen wirklich achten.
Artikel lesen →Was jede Beförderung vom RA Officer zum Head of Regulatory Affairs treibt und wie Sie sich für die nächste Stufe positionieren.
Artikel lesen →Die Einstiegswege in die Arzneimittelsicherheit, die tatsächlich funktionieren, und was ein Pharmakovigilanz-CV zeigen muss.
Artikel lesen →Wie Sie Ihre GMP-Erfahrung für einen Wechsel in die QA neu einordnen und was ein QA-Lebenslauf belegen muss.
Artikel lesen →Ein Insider-Recruiter vergleicht die zwei beliebtesten Pharma-Karrierewege und wie Sie wählen.
Artikel lesen →Warum Market Access und HEOR eine Prämie erzielen und wie das AMNOG-Verfahren das Feld prägt.
Artikel lesen →Die Algorithmen, mit denen Pharmaunternehmen Lebensläufe filtern, sind nicht so zufällig, wie sie sich anfühlen. So kommen Sie durch.
Artikel lesen →Rund 50–70 % der Senior-Rollen in der DACH-Pharma werden besetzt, bevor sie je auf einem Jobportal erscheinen. Wie Sie die Person werden, die Recruiter aktiv suchen.
Artikel lesen →Deutschland kann seine Stellen nicht besetzen und sortiert die Ü50 trotzdem aus. Altersdiskriminierung im DACH-Pharma-Recruiting 2026 — the data, the euphemisms, and five moves that actually work.
Artikel lesen →Die Statistik vom „80 % verdeckten Arbeitsmarkt“ stammt aus einer Broschüre von 1966. Die echten DACH-Zahlen, die Weak-Ties-Wissenschaft und welches Networking wirklich wirkt.
Artikel lesen →Der meistgemeldete LinkedIn-Jobbetrug 2026 ist der falsche Recruiter, der behauptet, Ihr Lebenslauf brauche ein kostenpflichtiges Rewrite. Wie es funktioniert, welches Zeichen es entlarvt, und wie Sie sicher bleiben.
Artikel lesen →54,000 German executives are unemployed — the highest since 2015. The DACH executive job market in 2026, the euphemisms, and five moves that actually work at any level.
Read article →AI auto-apply tools promise to job-hunt while you sleep. The data says they quietly torpedo your candidacy — and the EU AI Act regulates their robot, not yours.
Read article →22,000 Western pharma redundancies and a 62% Indian hiring surge are not separate phenomena — they are the same transaction. What it means for DACH pharma careers in 2026.
Read article →The '85% via networking' claim has no traceable source. The real number is 30–50% from referrals, and the actionable advice is more useful than the slogan.
Read article →Thirteen years watching pharma's technology waves. What AI will and won't take from medical writing, pharmacovigilance, biostatistics, and regulatory affairs in 2026.
Read article →Randstad Workmonitor 2026: 60% of German employees now rank job security above work-life balance. The data, the diagnosis, the strategy.
Read article →63.5% of applicants get no reply at all. The Indeed/Appinio survey, the EU Pay Transparency Directive (7 June 2026), and why pay transparency is the single biggest fix for ghosting in DACH pharma hiring.
Read article →Roughly 50–70% of senior DACH pharma roles are filled before they hit a job board. How to be the candidate recruiters source — not the one who applies in vain.
Read article →Germany's Opportunity Card is reshaping DACH pharma hiring competition. What it does, who is using it, and what it means for your salary and your next role.
Read article →Most pharma professionals treat LinkedIn as a CV. Recruiters read it as an argument. Here is how to write a profile that closes the case before paragraph two.
Read article →A former Big-Pharma recruiter debunks the five biggest ATS myths — the automatic 75% rejection, keyword mirroring, white-text hacks — and what actually moves your application.
Read article →If an employer you admire is hiring but has nothing that fits, pick up the phone. Why a two-minute call beats another cold application — from a recruiter who remembers the callers.
Read article →The honest answer from someone who screens CVs daily. What actually matters, what doesn't, and why the degree debate is more nuanced than LinkedIn thinks.
Artikel lesen →75% of CVs never reach a human recruiter — or do they? We separate ATS myth from reality, cover what DACH hiring actually looks like, and explain what changes from August 2026 under the EU AI Act.
Artikel lesen →93% of recruiters plan to increase AI use in 2026. Only 8% of candidates think AI makes hiring fair. What this really means for your pharma job search — and what the EU AI Act does about it.
Artikel lesen →Germany's four-day workweek trial results are in. What the data actually says about productivity, pharma hiring, and the future of work in DACH.
Artikel lesen →The EU Pay Transparency Directive is coming. How it reshapes pharmaceutical hiring in Germany, Austria, and Switzerland — and how to use it before everyone else does.
Artikel lesen →2027 is the year the patent cliff actually arrives, AI actually works, and your career either transforms or becomes obsolete. Here's the honest outlook.
Artikel lesen →180,000 new pharma jobs will be created in 2026 — and 95,000 will be destroyed. Here's how to be on the right side of that equation.
Artikel lesen →The patent cliff, AI disruption, and an outdated CV — three forces converging in 2026. What pharma professionals need to do now.
Artikel lesen →Pharma has an SOP for everything — except basic human decency in hiring. Five measures that could fix recruitment ghosting.
Artikel lesen →Let's play a game called "Spot the Fiction" — the uncomfortable truth about why your applications disappear into the void.
Artikel lesen →Job postings down 19%. Applications up 65%. Here's how to survive the most competitive pharma job market in a decade.
Artikel lesen →The pharma AI skills gap is 60%. For every 10 AI-competent candidates needed, only 4 exist. Here is what actually works to close that gap — and what is just expensive Quatsch.
Artikel lesen →42,700 pharmaceutical jobs eliminated in 2025 — 47% worse than 2024. What's really happening and what will actually save your career.
Artikel lesen →The viral LinkedIn post shaming a recruiter might feel good — but it's quietly destroying your chances. Here's what actually happens behind the scenes.
Artikel lesen →A thought experiment that reveals uncomfortable truths about modern hiring — and what you can do about it.
Artikel lesen →The algorithms that pharmaceutical companies use to filter CVs are not as random as they feel. Here is exactly how they work — and how to beat them.
Artikel lesen →LinkedIn removed 80.6 million fake accounts in six months. Job scams surged 1,000%. The red flags real recruiters spot — and the ones candidates miss.
Artikel lesen →After 16 years in pharmaceutical recruitment, some clients transformed their trajectories. Others burned through savings on glorified CV formatting services. Here's how to tell the difference.
Artikel lesen →Toyota became the world's largest car manufacturer through disciplined continuous improvement. The same principle applies to your pharma career — here's how.
Artikel lesen →220 million professionals now use LinkedIn's green "Open to Work" banner — a 35% surge. Is it helping or hurting your pharma job search?
Artikel lesen →After 16 years in pharmaceutical talent acquisition, watching exceptional candidates with decades of expertise get passed over — the age bias conversation pharma needs to have.
Artikel lesen →Stop sending your 847th application to a Senior Pharma role you're "technically qualified" for. Here's what actually gets you hired.
Artikel lesen →Yes, I said it. The badge that's supposed to help you get hired might be doing the opposite. Here's why — and what to do instead.
Artikel lesen →Learn in five minutes how LinkedIn connections and direct messages can become one of your best job-hunting tools in pharma.
Artikel lesen →It's not their experience. It's not their skills. After 16 years in pharma recruitment, I've seen exceptional candidates become invisible — because of acronyms.
Artikel lesen →A journalist let AI bots apply to jobs on her behalf. The results: £200 spent, wrong languages claimed, cover letters sent to the wrong companies. As a recruiter, I can assure you: we notice.
Artikel lesen →After 13 years in pharma recruitment: degrees open doors — but skills decide what happens once you're inside. Here's the cheat sheet.
Artikel lesen →A recruiter's take on cybersecurity: after 16 years in talent acquisition, here's why WhatsApp's latest breach matters for your career and data.
Artikel lesen →AI, drug discovery, and the billion-euro question: should pharmaceutical companies build their own supercomputers or rent someone else's?
Artikel lesen →Europe's 80% dependency on Asian pharmaceutical ingredients is a ticking time bomb. What it means for the industry and your career.
Artikel lesen →